Table 2.
Prognostic variables among patients undergoing and not undergoing adjuvant chemotherapy after pulmonary metastasectomy.
| Variables | Adjuvant (n = 42) | Non-adjuvant (n = 58) | P Value |
|---|---|---|---|
| Age (≥75 years) | 4 (10%) | 12 (21%) | 0.133 |
| Sex (Male) | 25 (60%) | 31 (53%) | 0.546 |
| Number (Multiple) | 15 (36%) | 13 (22%) | 0.144 |
| CEA (ng/ml) (≥5) | 9 (21%) | 15 (26%) | 0.608 |
| Nodal involvement (Yes) | 0 (0%) | 2 (3%) | 0.224 |
| Size (≥2 cm) | 9 (21%) | 23 (39%) | 0.054 |
| Primary site (Rectum) | 22 (52%) | 28 (48%) | 0.685 |
| pStage of CRC (III/IV) | 27 (64%) | 41 (70%) | 0.498 |
| Adjuvant CT after RC | 25 (60%) | 32 (55%) | 0.664 |
| LM before PM (Yes) | 6 (14%) | 13 (22%) | 0.307 |
| EPL before PM (Yes) | 14 (33%) | 20 (35%) | 0.905 |
| DFI (years) (≥3/< 3) | 9 (21%) | 12 (21%) | 0.907 |